Cornette L
Peter Congdon Neonatal Unit, Leeds General Infirmary, Leeds, UK.
Minerva Ginecol. 2005 Aug;57(4):411-21.
We here review the relation between feto-maternal and neonatal inflammatory/infective processes (e.g. chronic lung disease and necrotising enterocolitis) and their interaction with genetic and environmental factors. We also investigate the available evidence suggesting a link between perinatal inflammatory responses and neonatal (neuro)morbidity. Currently there does not appear to exist a silver bullet capable to prevent an impaired neurodevelopmental outcome in the event of a fetal and/or neonatal inflammatory response. A clear need thus exists for more epidemiology studies, using advanced techniques for laboratory research and neuro-imaging, with sufficiently long periods of follow-up. It is hoped that these studies will identify pre and postnatal inflammatory risk profiles, this through clarification of the relationship between inflammation markers and their expression in the fetal and neonatal circulation over time. Although such research will be complex, only then we may become successful in the development of new anti-inflammatory interventions in the newborn.
我们在此回顾胎儿-母体及新生儿炎症/感染过程(如慢性肺病和坏死性小肠结肠炎)之间的关系,以及它们与遗传和环境因素的相互作用。我们还研究了现有证据,这些证据表明围产期炎症反应与新生儿(神经)疾病之间存在联系。目前似乎不存在能够预防胎儿和/或新生儿炎症反应导致神经发育受损结果的万灵药。因此,迫切需要开展更多的流行病学研究,采用先进的实验室研究技术和神经影像学技术,并进行足够长时间的随访。希望这些研究能够通过阐明炎症标志物及其在胎儿和新生儿循环中的表达随时间的关系,确定产前和产后的炎症风险特征。尽管此类研究将很复杂,但只有这样我们才有可能成功开发针对新生儿的新型抗炎干预措施。